We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Novel Chromogenic Screening Medium Developed for MRSA

By LabMedica International staff writers
Posted on 13 Aug 2014
Print article
Image: Typical colonies of methicillin-resistant Staphylococcus aureus (MRSA) grew and formed blue-colored colonies on MRSA-chrom media after 24 hours of incubation at 35 °C (Photo courtesy of Kohjin Bio Co., Ltd).
Image: Typical colonies of methicillin-resistant Staphylococcus aureus (MRSA) grew and formed blue-colored colonies on MRSA-chrom media after 24 hours of incubation at 35 °C (Photo courtesy of Kohjin Bio Co., Ltd).
A novel chromogenic screening agar medium for methicillin-resistant Staphylococcus aureus (MRSA) has been developed, as rapid and definite detection of MRSA is important not only diagnosis but also for preventing the spread of this bacteria.

MRSA is known as a major nosocomial pathogen, which causes a variety of clinical symptoms including septicemia, pneumonia, and postsurgical toxic shock syndrome and treatment of infections by MRSA has been problematic since MRSA is resistant to many antimicrobial agents.

Scientists at the Kohjin Bio Co., Ltd. (Saitama, Japan) compared the company’s MRSA-chrom media with other commercially available media to detect MRSA. Forty-two strains of MRSA including 41 clinical isolates from nasal cavity were inoculated into the media for the inclusivity study. For the exclusivity study, 52 gram-positive strains other than MRSA, 36 gram-negative strains, and 3 yeasts were inoculated into suitable culture media.

A total of 42 MRSA strains grew and formed typical blue- and mauve-colored colonies on MRSA-chrom and CHROMagar MRSA (CHROMagar Microbiology; Paris, France) in 24 hours. Of 42 MRSA strains, 37 strains grew and formed typical yellow colonies with egg yolk turbid reaction for S. aureus on three other media in 48 hours. All of the other microbes tested including 17 methicillin-sensitive S. aureus (MSSA) strains failed to grow on MRSA-chrom. The colonies of Bacillus cereus were spread and had a frosted glass appearance and as a result, these colonies could be distinguished from MRSA easily. When the scientists tested the 50 clinical specimens, they found that both chromogenic media detected MRSA as typical colored colony from 33 specimens after 24 hours of incubation.

The authors concluded that the novel chromogenic medium, MRSA-chrom, developed for the screening of MRSA was excellent for both selectivity and detectability. Therefore, they suggested that MRSA-chrom was a useful alternative for rapid and definitely screening of MRSA. Moreover, MRSA-chrom had a good growth for MRSA since it contained no sodium chloride. The study was published in the August 2014 issue of the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

Kohjin Bio Co., Ltd.
CHROMagar Microbiology


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.